Amicus Therapeutics, Inc. (FOLD)
14.37
0.00 (0.00%)
USD |
NASDAQ |
Mar 16, 16:00
14.37
0.00 (0.00%)
After-Hours: 19:50
Amicus Therapeutics EPS Diluted (Quarterly) : 0.0054 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| CorMedix, Inc. | 0.1493 |
| Krystal Biotech, Inc. | 1.699 |
| MannKind Corp. | -0.0519 |
| Keros Therapeutics, Inc. | -0.8626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.69M |
| Revenue (Quarterly) | 185.21M |
| Total Expenses (Quarterly) | 183.52M |
| Enterprise Value | 4.661B |
| Gross Profit Margin (Quarterly) | 84.64% |
| Profit Margin (Quarterly) | 0.91% |
| Earnings Yield | -0.62% |
| Operating Earnings Yield | 0.77% |
| Normalized Earnings Yield | -0.5894 |